The CSF Aβ42/40 ratio is superior to Aβ42 alone as a marker of amyloid-positivity by PET. We hypothesize that this increase in performance reflects the ratio compensating for general between-individual variations in CSF total Aβ.
No takes yet. Share an insight, caveat, or question.
Lewczuk et al. (2016) studied this question.